|
Dan Levangie Joins Advisory Board It is my pleasure to announce that Dan Levangie has agreed to join the Advisory Board of the Barnett Institute. Dan will be a wonderful addition to the Board, given his broad and extensive experience in the health/diagnostic industry. Dan received his B.S. degree in Pharmacy from Northeastern University in 1973. He recalls being taught freshman chemistry by me in 1968. From 1975-1992 he held various positions in sales and marketing with Abbott Laboratories, ending as Regional Sales Manager of the Pharmaceutical Products Division. In 1992 he joined Cytyc Corporation, Boxborough, MA, the major company involved in the Pap smear test for women. He rose in the ranks of Cytyc to become President and Chief Operating Officer in 2001-2002. In the past 5 years, he has held major positions at Cytyc, most recently as President, Cytyc Surgical Products, a division of Cytyc Corporation. In November, 2007, Cytyc Corporation was sold to Hologic, Inc., Bedford, MA, a medical device/diagnostic company focusing on women's health. He is now a Director of Hologic, as well as Ev3, Minneapolis, MN, and Dune Medical, Ltd, Caesaria, IL. The Barnett Institute (Bill Hancock and myself) has had a very successful collaboration with Cytyc Corporation over the past three years discovering potential protein biomarkers for diagnostic purposes to augment the cytological assay of the Pap smear. Dan was involved in supporting this work and played a major role in the direction the research has taken. Dan's broad background in diagnostics and his extensive knowledge of this industry will be very valuable to the Barnett Institute as we continue our development. Please join me in welcoming Dan to the Advisory Board. We all look forward to his advice and insight as we move forward. Barry
L. Karger Director, Barnett Institute; |
 |
|
|
